TCL Archive Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship July 16, 2010
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Judge Rules First Amendment Protects Distribution Of Off-Label Use Information August 14, 1998
